Check-Cap Ltd. (NASDAQ:CHEK) Short Interest Down 78.2% in April

Check-Cap Ltd. (NASDAQ:CHEK) was the target of a significant decrease in short interest during the month of April. As of April 15th, there was short interest totalling 131,100 shares, a decrease of 78.2% from the March 31st total of 600,000 shares. Based on an average trading volume of 251,300 shares, the days-to-cover ratio is presently 0.5 days. Currently, 3.0% of the company’s stock are sold short.

Check-Cap Stock Performance

Shares of NASDAQ:CHEK traded up $0.02 during midday trading on Friday, hitting $2.29. The company’s stock had a trading volume of 22,716 shares, compared to its average volume of 206,415. The stock has a market capitalization of $13.37 million, a price-to-earnings ratio of -0.76 and a beta of 0.28. The stock’s 50 day simple moving average is $2.26 and its 200 day simple moving average is $2.56. Check-Cap has a fifty-two week low of $1.27 and a fifty-two week high of $4.63.

Wall Street Analyst Weigh In

Separately, StockNews.com assumed coverage on shares of Check-Cap in a research report on Tuesday. They set a “sell” rating on the stock.

Check-Cap Company Profile

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation.